OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
7803$30.5054

aetherAI Co Ltd

Advanced Medical Equipment & TechnologyVerified

aetherAI's capital structure is characterized by a market cap of TWD 2.71 billion, with 88.86 million shares outstanding, both basic and diluted, indicating no immediate dilution pressure. The company's liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available in the valuation snapshot, and no industry-specific preferred metrics are provided in the industry configuration. As a result, a direct comparison to cohort medians for profitability or returns cannot be made at this time. The company's revenue concentration and geographic exposure are not disclosed in the available data. No segment-specific revenue breakdown is provided, and there is no information on geographic diversification or major customer dependencies. Growth trajectory is not quantified in the outlook section, and no numeric deltas are provided for the current or next fiscal year. Historical revenue data is also not available in the input, limiting the ability to assess growth trends. Risk factors include an unassessed liquidity risk and a low dilution potential, with no near-term dilution expected based on the current share structure. No additional risk factors are disclosed in the risk assessment section. Recent events, including filings or transcripts, are not provided in the input data, and no specific disclosures or developments are available for analysis.

30-day price · 7803-0.85 (-2.9%)
Low$28.55High$36.80Close$28.70As of15 May, 00:00 UTC
Profile
CompanyaetherAI Co Ltd
Ticker7803.TWO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. aetherAI Co Ltd develops and commercializes advanced medical equipment and technology, primarily serving the healthcare services and equipment sector.

Classification. aetherAI is classified under the industry "Advanced Medical Equipment & Technology" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

aetherAI's capital structure is characterized by a market cap of TWD 2.71 billion, with 88.86 million shares outstanding, both basic and diluted, indicating no immediate dilution pressure. The company's liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available in the valuation snapshot, and no industry-specific preferred metrics are provided in the industry configuration. As a result, a direct comparison to cohort medians for profitability or returns cannot be made at this time. The company's revenue concentration and geographic exposure are not disclosed in the available data. No segment-specific revenue breakdown is provided, and there is no information on geographic diversification or major customer dependencies. Growth trajectory is not quantified in the outlook section, and no numeric deltas are provided for the current or next fiscal year. Historical revenue data is also not available in the input, limiting the ability to assess growth trends. Risk factors include an unassessed liquidity risk and a low dilution potential, with no near-term dilution expected based on the current share structure. No additional risk factors are disclosed in the risk assessment section. Recent events, including filings or transcripts, are not provided in the input data, and no specific disclosures or developments are available for analysis.
Key takeaways
  • aetherAI operates in the advanced medical equipment and technology sector with a classification confidence of 0.92.
  • The company has no immediate dilution pressure, with basic and diluted shares outstanding being equal.
  • Liquidity risk cannot be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • No profitability metrics or growth trajectory data are available for comparison to industry benchmarks.
  • Revenue concentration and geographic exposure are not disclosed, limiting visibility into operational risk factors.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3$37.6M-$101.4M-$98.4M-$91.3M
FY-2$101.8M-$74.9M-$74.1M-$77.0M
FY-1$101.0M-$136.1M-$121.8M-$129.1M
FY0$193.8M-$214.3M-$203.9M-$191.0M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3$177.1M$153.9M$26.1M
FY-2$185.7M$132.2M$65.8M
FY-1$905.1M$814.9M$531.3M
FY0$703.2M$608.8M$341.4M
PeriodOCFCapExFCFSBC
FY-4
FY-3-$74.3M-$1.6M-$91.3M
FY-2-$67.9M-$13.5M-$77.0M
FY-1-$104.3M-$22.7M-$129.1M
FY0-$109.4M-$11.9M-$191.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5$6.4M-$47.1M-$46.4M-$46.9M
FQ-4
FQ-3
FQ-2
FQ-1$90.3M-$39.8M-$23.0M-$17.9M
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5$886.8M$819.6M$148.0M
FQ-4
FQ-3
FQ-2
FQ-1$744.7M$660.6M$397.0M
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5-$66.9M-$10.0M-$46.9M
FQ-4
FQ-3
FQ-2
FQ-1-$146.4M-$10.7M-$17.9M
FQ0
Valuation
Market price$30.50
Market cap$2.71B
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Equipment · cohort 91 companies
Metric7803Activity
Op margin-16.5% medp25 -174.5% · p75 8.8%
Net margin-16.5% medp25 -172.4% · p75 8.4%
Gross margin47.4% medp25 34.2% · p75 65.3%
CapEx / revenue-5.4% medp25 -12.5% · p75 -2.2%
Debt / equity4.3% medp25 0.0% · p75 28.0%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:35 UTC#c948af8a
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 03:21 UTCJob: 0cec929a